CClinicalTrials.gg
RecruitingNCT06512025EQEPUpdated Feb 26, 2025

Implementation of a Psychoeducational Intervention in New Mothers

An interventional study of WWWT psychoeducative intervention in Depression, Postpartum and Anxiety, sponsored by Alba Roca. Recruiting at 2 sites in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-26.

Sponsored by Alba Roca · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this clinical trial is to implement and examine the clinical effectiveness in a randomized study of the Catalan and Spanish versions of the culturally adapted "What Were We Thinking (WWWT)" psychoeducational intervention in primary care services, with the aim of preventing and reducing the prevalence of postpartum mental illness in new mothers. Additionally, the trial will assess the acceptability and accessibility of the intervention by families and professionals.

Researchers will compare "Usual Care" (standard postnatal care provided by professionals from the Sexual and Reproductive Health Service) with "Intervention group" (usual care plus two psychoeducative intervention WWWT sessions) to see if the "WWWT intervention" is better than "Usual Care" at preventing postpartum depression and anxiety disorders in new mothers.

Participants will:

  • Take baseline questionnaires at 2-4 weeks postpartum
  • Take usual care or usual care plus two psychoeducative intervention WWWT sessions within the first 6 weeks postpartum
  • Take the same questionnaires used in baseline plus a semi-structured interview to diagnose major mental disorder (all participants) at 3 and 6 months follow-up
  • Take a brief anonymous self-report survey (only those participants taking the WWWT intervention)
02

Conditions studied

  • Depression, Postpartum
  • Anxiety

Keywords

  • Postpartum Period
  • Prevention
  • Preventive Health Care
  • Psychoeducation
  • Primiparity
  • Female
03

In context

Depression, Postpartum

528 studies on the registry are indexed under Depression, Postpartum; 124 are open to participants now.

This study's planned enrollment of 400 is above the median of 105 across 425 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

This is the only study on the registry with Alba Roca as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Primiparous women
  • Given birth a healthy, full-term baby in the preceding 2 weeks
  • Receiving postpartum healthcare at Atenció a la salut sexual i reproductiva (ASSIR) of Àrea Integral de Salut Barcelona Esquerra (AIS-BE)
  • Over 18 years of age
  • Give consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • If are unable to complete the questionnaires due to language or literacy barriers
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • No intervention
    Usual Care

    Participants will received the postpartum usual care at the Sexual and Reproductive Health Service (ASSIR).

  • Experimental
    WWWT psychoeducative intervention

    Participants will received the postpartum routine usual care plus two psychoeducative intervention WWWT sessions at the Sexual and Reproductive Health Service (ASSIR).

    Behavioral: WWWT psychoeducative intervention

Interventions

  • BehavioralWWWT psychoeducative intervention

    "What Were We Thinking" (WWWT) is a highly structured, interactive, gender-informed, couples-based, psycho-educational program for parents and a first newborn to promote confident parental caretaking, optimize functioning in the intimate partner relationship and improve infant care manageability. The adaptation of the WWWT programme (Catalan and Spanish version) comprises 2 sessions, each lasting 2 hours, that will be designed for groups of 5-7 families - within the first 6 weeks postpartum -, each consisting of mother, partner (or other caregiver) and their infant(s).

06

What researchers measure

Primary outcomes

  1. Mental Disorders

    The Mini-International Neuropsychiatric Interview (MINI) is a brief structured interview designed for the detection and diagnostic guidance of major Axis I psychiatric disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) and the International Classification of Diseases, 10th Edition (ICD-10). It has an administration time of approximately 15 minutes and is divided into 16 modules, identified by letters, each corresponding to a diagnostic category.

    Time frame: 3 and 6 months postpartum (follow-up)

  2. Depressive symptoms

    The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire that is used as a screening instrument and for research purposes. Item scores are summed up to a total score (from 0 to 30 points), with higher scores indicating a higher depressive symptom burden. At a cutoff value of 11 (EPDS ≥ 11), the sensitivity of detecting a clinically significant depression is 0.79, the specificity is 0.95, and the positive predictive value is 0.63. The scale has a good internal consistency (Cronbach's α = 0.81).

    Time frame: Baseline, 3 and 6 months follow-up

  3. Depressive symptoms

    The Beck Depression Inventory (BDI-II) is a 21-item self-report instrument designed to assess the severity of depressive symptomatology. In each item, the person evaluated must select the phrase that best describes their condition over the past two weeks from a list of four options, with seven alternatives in items 16 and 18. Each item is scored from 0 to 3 points, with the total score ranging from 0 to 63, with higher scores indicating a higher depressive symptom burden.

    Time frame: Baseline, 3 and 6 months follow-up

  4. Anxiety symptoms

    The Generalised Anxiety Disorder Screener (GAD-7) is a 7-item self-report scale used as a screening instrument measuring symptoms of generalized anxiety disorder that has been recommended as brief screening measure for perinatal anxiety. Item scores are summed up to a total score (from 0 to 21 points), with higher scores indicating a higher anxiety symptom burden. There are no cut-off points established for the Spanish version. In the original version, the authors propose a cut-off point of greater than or equal to 10. For the Spanish version, a Cronbach's alpha coefficient of 0.93 was obtained. Considering the 10-point cutoff, sensitivity values of 86.8% and specificity of 93.4% were found.

    Time frame: Baseline, 3 and 6 months follow-up

Secondary outcomes

  1. Maternal postpartum bonding

    The Postpartum Bonding Questionnaire (PBQ) is a 25-item self-report questionnaire used to evaluate the alterations of the maternal-filial bond in the postpartum period. It includes 4 subscales, with a total of 25 items, which are rated by the mother on a Likert-type scale from 0 to 5. The subscales are general factor, rejection and pathological anger, infant-centered anxiety, and incipient maltreatment scale. The Spanish adaptation and validation has an adequate psychometrics property for use with clinical and general population of Spanish puerperal women. The PBQ could be summarized in a general factor and that the use of the total score of the scale would already be useful to detect alterations in the mother-infant bond (Cronbach's alpha reliability value of 0.90). A total score of 26 or more would indicate some type of attachment disorder, and a score of 40 or more would indicate the presence of maternal rejection or a severe attachment disorder.

    Time frame: Baseline, 3 and 6 months follow-up

  2. Parenting self-regulation

    The Me as a Parent scale (MaaPs) is a 16-item self-report scale used to measure the parents' perceptions of their parenting role. The scale has four theoretical sub-dimensions (Parenting Self-Efficacy; Personal Agency; Self-Management; and Self-Sufficiency), each containing four items scored on a 5-point agreement scale, with a total scale score range of 16-80. Higher scores indicate a higher parent's self-perceived competence and efficacy.

    Time frame: Baseline, 3 and 6 months follow-up

  3. Marital Adjustment

    The Escala de Ajuste Diádico (EAD-13) is a 13-item self-report short version of the Dyadic Adjustment Scale (DAS) used to assess the degree of harmony or adjustment between the members of the couple's relationship through 3 dimensions: consensus (capacity, resources and skills to reach agreements or find joint solutions to problems), satisfaction (level of well-being, happiness and commitment in the couple) and cohesion (degree of involvement of one member of the couple with the other). Item scores are summed up to a total score (from 12 to 75 points), with higher scores indicating increased marital adjustment. The scale has shown adequate psychometric properties to be applied in the Spanish context, finding a Cronbach's alpha reliability value of 0.81.

    Time frame: Baseline, 3 and 6 months follow-up

  4. Satisfaction survey

    Satisfaction survey is made up of Likert-type questions from 0 to 5 points (1 = completely disagree, 5 = completely agree) and open questions to measure participants' satisfaction with the WWWT psychoeducational intervention in terms of accessibility, comprehensibility, acceptability and usefulness, and identify needs or possible difficulties in its implementation.

    Time frame: Intervention group participants immediately after completing the WWWT psychoeducative group.

Other outcomes

  1. Partner Violence

    The Woman Abuse Screening Tool (WAST) is 8-item self-report screening instrument for intimate partner physical, emotional and/or sexual violence. The items are answered on a scale of intensity or frequency of 3 degrees. The maximum score range of the scale ranges from 8 to 24, which is obtained from the sum of the responses of the 8 items of the scale. Higher scores indicate a higher risk of partner abuse. The scale It was translated and validated in Spanish population and finding good internal consistency (Cronbach's α = 0.95).

    Time frame: Baseline, 3 and 6 months follow-up

  2. Alcohol use

    The Alcohol Use Disorders Identification Test (AUDIT-C) is a shortened version of the AUDIT, comprising the initial three items. It is designed to facilitate the expedient identification of individuals engaging in hazardous alcohol consumption. Total scores range from 0 to 12, with elevated scores indicating heightened risk-taking drinking behaviors. The sensitivity of the AUDIT-C has been demonstrated to range from 54 to 98%, while its specificity has been shown to range from 57 to 93%, depending on the definition of heavy drinking employed

    Time frame: Baseline, 3 and 6 months follow-up

  3. Childhood trauma

    The Early Trauma Inventory Self Report Short-Form (ETISR-SF) is a 27-item self-report inventory that retrospectively assesses the presence of traumatic events experienced before and after the age of 18. It contains dichotomous items (yes or not) that assess general trauma, emotional, physical, or sexual abuse. The ETI-SF internal consistency ranged between 0.42 and 0.72, and test-retest reliability ranged from 0.84 to 0.96.

    Time frame: Baseline

  4. Vulnerable Personality Style

    The Vulnerable Personality Style Questionnaire (VPSQ) is a 9-item self-report scale used to assess personality traits which increase the risk of postpartum depression (coping, nervy, timidity, sensitivity, worrier, organised, obsessive, expressive and volatility). It is rated on a 5-point Likert scale (1 = "not at all" to 5 = "very much so"). Total scores range from 9 to 45, and higher scores indicate increased vulnerability.

    Time frame: Baseline

  5. Perceived Social Support

    The Multidimensional Perceived Social Support Scale (MSPPSS) is a 12-item measure of perceived adequacy of social support from three sources: family, friends and significant other; using a 5-point Likert scale (0 = strongly disagree, 5 = strongly agree).

    Time frame: Baseline, 3 and 6 months follow-up

  6. Sociodemographic variables

    Age, country of birth, current marital status, occupation prior to having the infant, highest level of education completed, employment, will be collected by an ad hoc questionnaire.

    Time frame: Baseline

  7. Psychiatric history, clinical and health variables

    Self-rated general health, maternal rating of infant general health, history of diagnosed mental health problems (included substance use) and history of physical and sexual abuse will be collected by an Ad hoc questionnaire.

    Time frame: Baseline

  8. Obstetrical and neonatal outcomes

    Obstetric history (previous pregnancies and abortions), type of conception (spontaneous or using Assisted Reproductive Technology), unplanned pregnancy, mode of birth, singleton infant or multiples, sex of infant, birth weight (grams), week of pregnancy when delivery took place, overall birth experience, and method of feeding the baby (breastfeeding, mixed feeding, bottle feeding) will be assessed by an Ad hoc questionnaire.

    Time frame: Baseline

  9. Baby's temperament

    The Baby Temperament Scale is a 10-item scale that allows obtaining an individualized profile of 9 basic temperamental traits, and a classification between three pure categories: slow child, difficult child and active child. Each dimension allows three response options: two opposite and one intermediate. It is not an instrument with psychometric validation.

    Time frame: Baseline, 3 and 6 months follow-up

07

Study locations

1 of 2 sites recruiting
  • Unitat de Salut Mental Perinatal (USMP) de l'Hospital Clínic de Barcelona
    Barcelona, 08036, Spain
    • Alba Roca-Lecumberri, Doctor · Contact · aroca1@clinic.cat · +34653092959
    • Noelia Fernández-Jarabo, Graduate · Contact · fernandez15@recerca.clinic.cat · +34691045604
    • Noelia Fernández-Jarabo, Graduate · Contact
    • Lluïsa Garcia-Esteve, Doctor · Contact
    • Eva Solé Roige, Doctor · Contact
    • Susana Andrés Perpiñá, Doctor · Contact
    • Anna Torres Gimenez, Doctor · Contact
    Not yet recruiting
  • Atenció a la salut sexual i reproductiva (ASSIR) de l'Àrea Integral de Salut Barcelona Esquerra (AIS-BE)
    Barcelona, Spain
    • Judit Pelegrí, Diplomat · Contact · jpelegri.bcn.ics@gencat.cat
    • Julia M Cid, Diplomat · Contact
    • Loida Lucas, Diplomat · Contact
    • Sara Albero, Diplomat · Contact
    • Judit Pelegrí, Diplomat · Contact
    • Blanca Albillos, Diplomat · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06512025
Lead sponsor
Alba Roca
Collaborators
Fundació La Marató de TV3, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Universitat Autonoma de Barcelona
Responsible party
Alba Roca (Doctor, Fundacion Clinic per a la Recerca Biomédica) — Sponsor-investigator
First posted
Jul 22, 2024
Start date
Nov 8, 2024
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Feb 26, 2025

Study contacts

Alba Roca, Doctor
Contact
aroca1@clinic.cat
+34653092959
Noelia Fernández, Graduate
Contact
fernandez15@recerca.clinic.cat
+34691045604
Alba Roca, Doctor
principal investigator · Fundacion Clinic per a la Recerca Biomédica

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion